New nasal spray offers hope for depression patients Who've tried everything else
NCT ID NCT07053345
Summary
This study is testing whether esketamine nasal spray can help reduce depression symptoms in Korean patients whose depression hasn't improved with at least two standard antidepressant medications. Researchers will measure changes in depression scores over 4 weeks of treatment. The study is open-label, meaning everyone receives the nasal spray, and it focuses specifically on the Korean population.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, TREATMENT-RESISTANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
-
Cha Ilsan Medical Center
RECRUITINGGoyang Si Gyeonggi Do, 10414, South Korea
-
Kangbuk Samsung Hospital
RECRUITINGSeoul, 03181, South Korea
-
Kyung Hee University Hospital
RECRUITINGSeoul, 130 050, South Korea
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
-
Wonkwang University Hospital
RECRUITINGIksan, 570 711, South Korea
Conditions
Explore the condition pages connected to this study.